Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE